We are live on
!
Find out more
GSC
G&S Capital Portfolio holdings
AUM
$345M
1-Year Est. Return
32.53%
This Fund
S&P 500
This Quarter
Est. Return
-9.31%
1 Year Est. Return
+32.53%
3 Year Est. Return
+77.18%
5 Year Est. Return
+99.48%
10 Year Est. Return
–
AUM
$170M
AUM Growth
-$17.5M
(-9.3%)
Cap. Flow
+$1.02M
Cap. Flow
% of AUM
0.6%
Top 10 Holdings %
Top 10 Hldgs %
37.69%
Holding
119
New
14
Increased
46
Reduced
24
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$10.2M |
| 2 |
First Trust Enhanced Short Maturity ETF
FTSM
|
+$6.12M |
| 3 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$3.32M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$2.9M |
| 5 |
UnitedHealth
UNH
|
+$2.77M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$3.98M |
| 2 |
Kroger
KR
|
+$2.85M |
| 3 |
Illinois Tool Works
ITW
|
+$2.76M |
| 4 |
Home Depot
HD
|
+$2.1M |
| 5 |
Palo Alto Networks
PANW
|
+$2.05M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 7.25% |
| 2 | Healthcare | 6.9% |
| 3 | Energy | 5.93% |
| 4 | Industrials | 5.79% |
| 5 | Technology | 5.01% |
Similar funds
OPW
PFMOSF
AIM
ICM
SEEDPG
GLCM
VW
FFA
G&S Capital's Q2 2022 Portfolio in Review
As of Q2 2022, G&S Capital held 119 positions worth $170M, down 9.3% from $187M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
G&S Capital's Q2 2022 filing shows 14 new, 46 increased, 24 reduced and 31 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 122,697 shares worth $10.2M. The largest sale was iShares Biotechnology ETF, an estimated $3.98M.
By sector, the portfolio is most concentrated in Consumer Staples at 7.3% of assets, up from 6.3% a quarter earlier, followed by Healthcare and Energy.
- G&S Capital's largest Q2 2022 buy was iShares 1-3 Year Treasury Bond ETF: 122,697 shares worth $10.2M.
- G&S Capital added most to Goldman Sachs Access Treasury 0-1 Year ETF in Q2 2022, an estimated $3.32M increase.
- G&S Capital's biggest Q2 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.05M.
- G&S Capital fully exited iShares Biotechnology ETF in Q2 2022, selling an estimated $3.98M.
- G&S Capital's ten largest holdings make up 38% of its $170M portfolio in Q2 2022.
- G&S Capital opened 14 new positions and closed 31 in Q2 2022.
- G&S Capital's portfolio value fell 9.3% quarter-over-quarter to $170M.
Based on G&S Capital's 13F filing for Q2 2022, filed 21 Jul 2022.